-
Fully Integrated High Throughput Antibody Screening and Characterization Platform
Perform large competition assays such as epitope binning of 384×384 mAbs in 10% of the time using 1% of the sample requirements of other systems.
-
Highest Throughput Epitope Binning Available
Maximize epitope diversity, identify unique epitopes and build your IP portfolio.
-
High Throughput Kinetics: Rapidly Screen up to 1152 Samples in a Single Assay
No compromise throughput and data quality with powerful batch-mode processing that enables rapid data analysis of large data sets.
-
Visit us at Booth #10 at the Antibody Engineering & Therapeutics conference in Amsterdam, Netherlands.
Learn how to accelerate the discovery of therapeutic antibodies at our poster presentation.
High Throughput Kinetics
The LSA changes the paradigm, delivering flow-based kinetics for coupled (up to 384 in parallel) and capture (up to 1152 in a single run) formats, enabling rapid screening of mAb libraries for affinity, association and dissociation constants.
Epitope Binning
Characterize and group (bin) up to 384×384 mAbs by the epitope binding regions generated against a specific antigen using the LSA’s simple to use classical and pre-mix methods to maintain epitope diversity and provide important information to broaden intellectual property protection.
Quantitation
Rapidly determine the mAb concentration of up to 1152 clones in parallel to aid in production QC and subsequent screening and selection using the LSA Quant App.
Epitope Mapping
Antibody epitope discovery at the amino acid level by immobilizing a panel of up to 384 biotinylated peptides with overlapping sequences and screening mAbs to ‘map’ and compare their binding.
News & Events
Event
06.12.19 through 06.13.19Antibody Engineering & Therapeutics Europe
Visit us at Booth #10 at the Antibody Engineering & Therapeutics conference in Amsterdam, Netherlands. Learn how to accelerate the discovery of therapeutic antibodies at our poster presentation.
News
03.19.19BioTechniques Article on Accelerating Biotherapeutic Discovery with High Throughput SPR
High throughput SPR is revolutionizing antibody screening for drug discovery, allowing screening and characterization to be accomplished in the same step, at the very beginning of the discovery process.
